AAC Holdings, Inc. (AAC)
AAC Holdings (AAC) Reports Q2 Loss, Misses Revenue Estimates
AAC Holdings (AAC) delivered earnings and revenue surprises of -400.00% and -12.15%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: AAC Holdings (AAC) Q2 Earnings Expected to Decline
AAC Holdings (AAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AAC Holdings, Inc. (AAC) CEO Michael Cartwright on Q1 2019 Results - Earnings Call Transcript
AAC Holdings, Inc. (NYSE:AAC) Q1 2019 Earnings Conference Call May 09, 2019, 10:00 ET Company Participants Andrew McWilliams - CFO Michael Cartwright - Chairman
ImmunoGen and Athenex among healthcare gainers; AAC Holdings and PetMed Express among losers
Gainers: Athenex (ATNX) +22%. Ovid Therapeutics (OVID) +16%. Daxor (DXR) +16%. ImmunoGen (IMGN) +16%. Guardion Health Science (GHSI) +10%. Losers: CohBar
AAC Holdings stock price target cut to $5 from $7 at Raymond James
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.